InnovAge Holding Corp. (INNV) News
Filter INNV News Items
INNV News Results
|Loading, please wait...|
Latest INNV News From Around the Web
Below are the latest news stories about InnovAge Holding Corp that investors may wish to consider to help them evaluate INNV as an investment opportunity.
Robert W. Baird analyst Vikram Kesavabhotla maintained a Buy rating on InnovAge Holding (INNV – Research Report) on February 13 and set a price target of $6.00. The company's shares closed last Wednesday at $4.98, close to its 52-week low of $3.46. According to TipRanks.com, Kesavabhotla is ranked 0 out of 5 stars with an average return of -12.7% and a 38.3% success rate. Kesavabhotla covers the Technology sector, focusing on stocks such as Tabula Rasa HealthCare, GoodRx Holdings, and SOC Telemed. The word on The Street in general, suggests a Hold analyst consensus rating for InnovAge Holding with a $5.00 average price target.
DENVER, Feb. 14, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail dual-eligible seniors, announced that Patrick Blair, Chief Executive Officer, and Barb Gutierrez, Chief Financial Officer, will participate in the upcoming 2022 Citi Virtual Healthcare Conference on Wednesday, February 23, 2022, including a fireside chat at 10:15 a.m. (ET). The appearance will be webcast live, and the webcast lin
DENVER, Feb. 09, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced financial results for its fiscal second quarter ended December 31, 2021. “We ended the fiscal second quarter with a census of approximately 7,050 participants, generated $175.4 million of revenue, and we are working diligently to address the deficiencies that were identified in the Sacramento a
Investment company Welch Capital Partners Llc (Current Portfolio) buys Hilton Grand Vacations Inc, InnovAge Holding Corp, Fidelity MSCI Information Technology Index ETF, Microsoft Corp, Fidelity MSCI Communication Services Index ETF, sells Invesco S&P 500 Equal Weight ETF during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Welch Capital Partners Llc.
InnovAge to Announce Fiscal Second Quarter 2022 Financial Results and Host Conference Call Wednesday, February 9, 2022
DENVER, Jan. 27, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV) will release its 2022 fiscal second quarter financial results on Wednesday, February 9, 2022, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. Conference Call DetailsThe conference call can be accessed by dialing (833) 398-1024 for U.S. participants, or (914) 987-7722 for international participants, and referencing participant code 9797448.
The CEO who played a significant role in the dramatic expansion of government-funded home and community-based care for frail seniors has stepped down from the company she built as regulatory concerns continue to mount. Maureen Hewitt resigned as chief executive of InnovAge Holding (INNV) effective January 1, the Denver-based company announced Monday. InnovAge is the largest provider in the Program of All-Inclusive Care for the Elderly (PACE), a Medicare- and Medicaid-funded service designed to meet all the healthcare needs of frail seniors while keeping them out of nursing homes.
InnovAge Announces the Resignation of CEO Maureen Hewitt and the Appointment of Patrick Blair as President and CEO
DENVER, Jan. 03, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV) accepted the resignation of longtime CEO and director Maureen Hewitt, effective January 1, 2022, who has decided after 15 years with the company to pursue other opportunities. The Board also elevated Patrick Blair, the President of InnovAge, to the position of President and CEO. InnovAge Board Chair Andrew Cavanna stated: “Patrick is a proven and effective leade
Investors need to pay close attention to InnovAge (INNV) stock based on the movements in the options market lately.
In a report issued on December 23, Lisa Gill from J.P. Morgan maintained a Hold rating on InnovAge Holding (INNV – Research Report), with a price target of $6.00. The company's shares closed last Monday at $4.71. According to TipRanks.com, Gill is a 5-star analyst with an average return of 17.4% and a 63.3% success rate. Gill covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Lifestance Health Group, and Alignment Healthcare. The word on The Street in general, suggests a Hold analyst consensus rating for InnovAge Holding with a $6.58 average price target, a 23.7% upside from current levels.
By Dhirendra Tripathi